Categories: News

Spheryx Introduces xSight, a Revolutionary Particle Characterization Instrument, with Live Demonstrations at the 10th Annual PEGS Boston, April 8-12, 2019.

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, April 4, 2019 /PRNewswire/ — Spheryx, Inc. will demonstrate xSight, their particle characterization instrument at PEGS Boston, April 8-12, 2019, in the Exhibit Hall at Seaport World Trade Center, Booth 500. PEGS Boston is the largest biologics event, drawing over 2,600 international participants interested in collaborating and sharing best practices in biologic therapeutics. xSight, uses Spheryx’s proprietary technology, Total Holographic Characterization®, to detect, count and characterize sub-visible particles in complex heterogeneous mixtures, including protein aggregates, a known safety hazard in biologic pharmaceuticals.

Solutions for Suspensions (PRNewsFoto/Spheryx, Inc.)Solutions for Suspensions (PRNewsFoto/Spheryx, Inc.)

Additionally, Spheryx was selected from 4,500 applicants to participate in the Hello Tomorrow Global Summit in Paris, an annual competition to showcase start-ups that solve an unmet industrial, environmental or societal need.

Spheryx announces the addition of Dr. Ross Boltyanskiy in the roll of Senior Scientist. Dr. Boltyanskiy received his PhD in physics from Yale University, and was a Postdoctoral Research Fellow at Memorial Sloan Kettering. Dr. Laura Phillips, President and CEO, stated, “We are delighted to have Dr. Boltyanskiy on board. With his expertise in microscopy, opto-mechanical technology and data visualization, he is a welcome addition to the Spheryx team.”

About Spheryx, Inc.
Spheryx, Inc. is a privately held analytical services and instruments company providing Total Holographic Characterization® of colloidal materials. Spheryx’s proprietary technology uses holographic video microscopy to characterize each particle in colloidal dispersions and multi-component colloidal mixtures, offering unprecedented insights into these materials’ characteristics. Applications include R&D, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, improve safety and reduce costs. For more information: https://www.spheryx.solutions/

Note: This news release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or result to differ materially.

Contact: Laura Philips, CEO
lphilips@spheryx.solutions  
607-738-0100

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/spheryx-introduces-xsight-a-revolutionary-particle-characterization-instrument-with-live-demonstrations-at-the-10th-annual-pegs-boston-april-8-12-2019-300824410.html

SOURCE Spheryx, Inc.

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

7 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

7 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

10 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

10 hours ago